Hospira Cisplatin Injection 100 mg/100 mL vial

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

cisplatin, Quantity: 1 mg/mL

Disponible desde:

Hospira Australia Pty Ltd

Designación común internacional (DCI):

Cisplatin

formulario farmacéutico:

Injection

Composición:

Excipient Ingredients: sodium hydroxide; hydrochloric acid; sodium chloride; mannitol; water for injections

Vía de administración:

Intravenous Infusion

Unidades en paquete:

1 x 100 mL vial

clase:

Medicine Listed (Export Only)

tipo de receta:

(S1) This Schedule is intentionally blank

indicaciones terapéuticas:

Cancer Chemotherapeutic drug - details of the indications do not appear on the leaflet as exported from Hospira Australia

Resumen del producto:

Visual Identification: A clear, colourless to pale yellow solution, free from visible particulates; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 24 Months; Container Temperature: Store between 15-25 degrees Celsius; Container Closure: Child resistant closure and restricted flow insert

Estado de Autorización:

Licence status A

Fecha de autorización:

2007-08-30